This weight loss injection is a dual incretin agonist that simultaneously targets GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors
Some people choose to switch specifically because B6 targets nausea more directly than the B12 formulation
Aspirational Pneumonia Risk Linked to Ozempic, Wegovy and Other GLP-1 Medications During Endoscopy Procedures: Study Findings align with warnings issued by anesthesiologists last summer about Ozempic aspiration risks, following reports of life-threatening problems caused by delayed gastric emptying during surgery
[2] Weiss JB, Phillips CJ, Malin EW, Gorantla VS, Harding JW, Salgar SK
Patients on GLP-1 therapy should be educated to seek immediate medical evaluation if these symptoms occur, as early recognition improves outcomes and guides treatment decisions
For those comparing exercise strategies across different GLP-1 compounds, the principles here apply broadly